Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance

A study to see whether a medication called Angiotensin II works better than the routinely used medication to raise blood pressure in people with liver disease who are experiencing a serious drop in blood pressure. The investigators want to find out if Angiotensin II can help the heart and blood vessels work together more effectively than standard treatments.

NCT Number	NCT07568275
Lead Sponsor	The Cleveland Clinic Collaborators: Innoviva Specialty Therapeutics
Conditions	Septic Shock, Cirrhosis, Vasodilatory Shock, Acute Kidney Injury
Enrollment	30 participants
Start Date	2024-11-15
Primary Completion	2028-01 (estimated)
Study Completion	2028-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-05